HomeAnalysisOrgan Donation in India Still Hinges on Family Luck

Organ Donation in India Still Hinges on Family Luck

A second liver transplant performed on a 30-year-old Mumbai resident has brought renewed attention to a structural weakness in India’s transplant system: even when surgical capability exists, access to a deceased donor remains uncertain. Nearly two decades after receiving part of his father’s liver as an 11-year-old, Jitin Shirke again depended on a living family member, this time his mother, when his first graft failed after 19 years.

The surgery at Jaslok Hospital was medically unusual because Shirke became part of a small group of patients in India to undergo a second liver transplant after a long period of survival with the first graft, according to transplant specialists quoted by The Times of India. But the circumstances surrounding the procedure point to a more familiar problem. India’s transplant system has expanded, yet deceased-donor organs remain too scarce to reliably meet urgent demand.

Shirke, an Andheri resident, was placed on the Zonal Transplant Coordination Centre recipient list in mid-June after his condition deteriorated. He said he became unconscious for four days and doctors advised that an immediate transplant was required. His mother was subsequently assessed and found eligible to donate part of her liver.

Doctors at Jaslok said Shirke suffered from autoimmune cirrhosis and experienced late rejection of the original graft. Graft failure, they noted, generally occurs in the early period after transplantation, making the 19-year survival of his first graft notable. The immediate availability of an eligible parent allowed the second procedure to proceed when time was limited.

That outcome, however, should not be mistaken for a dependable model of access. Dr Aabha Nagral, a liver transplant specialist involved in the case, said deceased organ donors remain too few and that only a small number of patients are fortunate enough to find an eligible living donor in their immediate family at short notice. The observation captures the central divide in India’s transplant system: living donation can provide an alternative, but it is dependent on family relationships, medical compatibility and the ability of relatives to assume the physical and emotional burden of donation.

The numbers cited in the report show both progress and limitation. Deceased-donor liver transplants increased from three in 2007 to 34 by July of the year covered in the report. That is a substantial rise in absolute terms, but the base remains small when measured against the country’s overall transplant needs. Ministry of Health and Family Welfare data cited by the report indicate that only 18% to 20% of transplants in India come from deceased donors. About 80% are from living donors.

This distribution is sharply different from that of developed nations, where deceased donors account for 85% to 95% of transplants, according to the same report. The comparison is important because it separates two parts of transplant capacity that are often treated as one. A country may have hospitals capable of performing complex procedures, specialists trained in transplant medicine and a legal framework governing donation, while still failing to generate enough organs from deceased donors.

For patients, that gap becomes most visible when illness progresses quickly. Shirke was placed on the recipient list in mid-June, but his condition worsened within weeks. In such cases, a waiting list is not only an administrative register. It is also a measure of whether the system can identify a suitable organ, coordinate its retrieval and allocation, and move it to a hospital before the patient’s condition becomes irreversible.

The report does not provide the total number of people waiting for liver transplants, the number of patients who die while waiting, or the number of hospitals licensed to conduct transplants. Those figures would be necessary to measure the full scale of the problem. What the case does establish is more specific: a patient requiring urgent retransplantation could access a procedure because a close family member was medically eligible to donate, while the deceased-donor system could not provide a timely alternative.

Mumbai’s transplant history also reflects the infrastructure challenge. Shirke recalled that his family had to visit multiple hospitals before his first transplant in 2007 because very few facilities had the required infrastructure at the time. Since then, transplant medicine has developed, but the availability of advanced surgery alone has not resolved the wider chain of requirements behind organ donation.

That chain includes identifying brain-stem deaths, obtaining consent, maintaining potential donors, retrieving organs, allocating them through the appropriate coordination system and transporting them within strict time limits. The report does not quantify performance at each stage. However, the comments from Dr S K Mathur, who performed Shirke’s first transplant and now serves as president of the Zonal Transplant Coordination Centre, place hospital monitoring at the centre of the debate.

Mathur said hospitals holding transplant licences should be regularly audited by the government. Such audits, he argued, should examine the number of brain-stem deaths identified, donations processed and awareness efforts undertaken. His proposal shifts attention from public appeals for donation to institutional performance. The question is not only whether people are willing to donate, but whether hospitals are consistently recognising potential donors and converting that opportunity into a completed donation.

This is a governance issue as much as a medical one. India’s Transplantation of Human Organs Act was passed in 1994, a decade after similar legislation in the United States, Mathur said. The law created a formal framework for transplantation, but the functioning of that framework depends on hospitals, transplant coordinators, state authorities and zonal agencies carrying out their responsibilities in practice.

The Zonal Transplant Coordination Centre is one link in that institutional structure. Shirke’s placement on its recipient list shows the role of a coordinating body in registering patients and managing access to organs. Yet coordination can only work effectively when hospitals report potential donors, families receive timely counselling, and organs are retrieved and allocated through an operational network. A waiting-list system without a reliable donor pipeline cannot guarantee timely treatment.

Living donation has helped India expand transplant access, but it also places the system’s burden on families. In Shirke’s case, his father donated part of his liver when he was a child, and his mother later became the donor for a second transplant. The family’s willingness and medical eligibility were decisive. Another patient in a similar condition may not have a relative who can donate, may not meet medical criteria, or may not have access to a hospital capable of performing the procedure.

The high share of living-donor transplants therefore indicates more than clinical preference. It also reflects the uneven availability of deceased organs. A living donor can be identified within a patient’s immediate network, while a deceased donation system requires public awareness, hospital protocols, trained staff, legal compliance and coordination across institutions. The two forms of donation are not interchangeable from an access perspective.

The contrast with developed nations cited in the report further underlines the institutional gap. Where deceased donors account for most transplants, access is less dependent on whether a patient’s immediate family contains a compatible donor. India’s 18% to 20% deceased-donor share leaves a much larger role for family-based donation. The result is a system in which medical capability may be available, but the route to treatment remains strongly shaped by personal circumstance.

The case also raises a question about how transplant success is measured. A long-surviving graft represents a positive clinical outcome, and Shirke’s 19 years with his first transplant demonstrates the possibility of durable treatment. But long-term success can eventually create a new demand for the system when a graft fails and a patient requires retransplantation. As more patients survive for longer after transplantation, transplant programmes must manage not only first-time procedures but also complex repeat cases.

The supplied report does not establish whether repeat liver transplants are increasing nationally or how many patients require them. It does show that retransplantation can become urgent after years of stability. That makes donor availability relevant across the full life cycle of transplant care, not only at the first intervention.

For Mumbai, the institutional question is particularly immediate because the city is home to major hospitals, specialist doctors and a zonal coordination mechanism, yet the reported case still depended on a family donor. The city’s advanced medical facilities can perform complex procedures, but their effectiveness is linked to systems beyond the operating theatre. Brain-stem-death identification, donor counselling, authorisation, retrieval and allocation determine whether a patient can benefit from the infrastructure that hospitals have built.

The evidence in this case supports a measured conclusion. India has made progress in transplant capability and has recorded an increase in deceased-donor liver transplants from the very low level reported in 2007. However, deceased donors still account for a minority of transplants, and the country remains far more dependent on living family donors than developed nations cited in the report.

What remains unclear is how consistently licensed hospitals are audited, how many potential donations are lost at different stages, and whether coordination capacity has expanded in line with surgical capability. Those are the measures that would show whether the system is improving beyond individual success stories. Until that evidence is available, Shirke’s second transplant stands as both a remarkable medical outcome and a reminder that, in India, access to a life-saving organ can still depend on whether a family member is able and willing to step forward.


RELATED ARTICLES

Most Popular

Latest News